Spots Global Cancer Trial Database for Magnesium Sulphate and Rocuronium in Patients Over 60
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Magnesium Sulphate and Rocuronium in Patients Over 60
Official Title: Effects of Magnesium Sulphate on the Pharmacodynamics of Rocuronium in Patients 60 Years or Older: Randomised and Double-Blind Study
Study ID: NCT01804205
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the effects of MgSO4 administration on the pharmacodynamics of rocuronium in patients with 60 or more years of age.
Detailed Description:
Eligibility
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Instituto Nacional de Câncer, Rio de Janeiro, , Brazil
Contact Details
Name: Pedro Rotava, MD
Affiliation: Instituto Nacional de Cancer
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
